Talk:Mitomycins
Latest comment: 10 months ago by Vanderwaalforces in topic Requested move 31 December 2023
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
 | On 31 December 2023, it was proposed that this article be moved from Mitomycin to Mitomycins. The result of the discussion was moved. |
Further reading
editMoved from the article as primary research and/or WP:ELNO. --Zefr (talk) 17:44, 11 November 2017 (UTC)
- Hata, T.; Sano, Y.; Sugawara, R.; Matsumae, A.; Kanamori, K.; Shima, T.; Hoshi, T. (1956). "Mitomycin, a new antibiotic from Streptomyces". J. Antibiot. Ser. A. 9: 141–146.
- Fukuyama, T.; Yang, L. (1987). "Total Synthesis of (±)-Mitomycins via Isomitomycin A". J. Am. Chem. Soc. 1987'. 109 (25): 7881–7882. doi:10.1021/ja00259a046.
{{cite journal}}: Italic or bold markup not allowed in:|journal=(help) - Mao, Y.; Varoglu, M.; Sherman, D.H. (April 1999). "Molecular characterization and analysis of the biosynthetic cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564". Chemistry & Biology. 6 (4): 251–263. doi:10.1016/S1074-5521(99)80040-4. PMID 10099135.
- Varoglu, M.; Mao, Y.; Sherman, D.H. (2001). "Mapping the Biosynthetic Pathway by Functional Analysis of the MitM Aziridine N-Methyltransferase". J. Am. Chem. Soc. 123 (27): 6712–6713. doi:10.1021/ja015646l. and references therein.
Requested move 31 December 2023
edit- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.
The result of the move request was: moved. (closed by non-admin page mover) Vanderwaalforces (talk) 13:26, 17 January 2024 (UTC)
Mitomycin → Mitomycins – This article is about mitomycins. Mitomycin, as the article notes, generally refers to Mitomycin-c, and Mitomycin should redirect there after the move. @Boghog, thanks for fixing my last edit. Agree? RudolfoMD (talk) 08:32, 31 December 2023 (UTC) — Relisting. SkyWarrior 16:43, 7 January 2024 (UTC)
- Hi RudolfoMD. Since the INN for the drug is Mitomycin and the drug is probably the WP:PRIMARYTOPIC, I agree that Mitomycin-C should be moved to Mitomycin. The only remaining question is what to call the current Mitomycin article. Per WP:PLURAL, the singular is generally preferred, but the plural may be used for groups or classes of specific things. Therefore "Mitomycins" should work. However some might find it confusing to have on article on Mitomycin and a second on Mitomycins. Perhaps it would be better to move the current article to "Mitomycin (natural product)". Cheers. Boghog (talk) 09:51, 31 December 2023 (UTC)
- Hi, Thanks for the input. I think my proposal, under which Mitomycin will be just a redirect to "Mitomycin-c" is less confusing. I read your comment as being OK with either. This has been up for 7 days, but I'll wait more, as SkyWarrior recently notified folks. RudolfoMD (talk) 06:01, 11 January 2024 (UTC)
- Note: WikiProject Pharmacology has been notified of this discussion. SkyWarrior 16:43, 7 January 2024 (UTC)
- Note: WikiProject Chemicals has been notified of this discussion. SkyWarrior 16:43, 7 January 2024 (UTC)
The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.